CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Medicine, Inc. (NASDAQ: FMI) today announced that financial results
for the company's third quarter ended September 30, 2013 will be
released on Wednesday, November 6, 2013. The management team will host a
conference call discussing the company's financial results and recent
developments on Wednesday, November 6, 2013 at 4:30 p.m. (ET). The call
can be accessed by dialing 1-877-941-2069 (domestic) or 1-480-629-9713
(international) five minutes prior to the start of the call and
providing the passcode 4647488.
The live, listen-only webcast of the conference call can be accessed by
visiting the investors section of the Foundation Medicine website at
investors.foundationmedicine.com. A replay of the webcast will be
available shortly after the conclusion of the call and archived on the
company's website for two weeks following the call.
About Foundation Medicine
Foundation Medicine® (NASDAQ: FMI) is a molecular information
company dedicated to a transformation in cancer care in which treatment
is informed by a deep understanding of the genomic changes that
contribute to each patient's unique cancer. The company's initial
clinical assay, FoundationOne™,
is a fully informative genomic profile to identify a patient's
individual molecular alterations and match them with relevant targeted
therapies and clinical trials. Foundation Medicine's molecular
information platform aims to improve day-to-day care for patients by
serving the needs of clinicians, academic researchers and drug
developers to help advance the science of molecular medicine in cancer.
For more information, please visit www.FoundationMedicine.com
or follow Foundation Medicine on Twitter
Foundation Medicine® is a registered
trademark, and FoundationOne™ is a trademark,
of Foundation Medicine, Inc.
Pure Communications, Inc.
Foundation Medicine, Inc.
Source: Foundation Medicine, Inc.
News Provided by Acquire Media